期刊文献+

厌氧菌介导的CD/5-FC系统对鼠黑色素瘤的杀伤效应 被引量:1

The Killing Effect of CD/5-FC System Delivered by Anaerobic Bacteria on Melanoma Cell of Mice
下载PDF
导出
摘要 目的构建婴儿双歧杆菌介导的CD/5-FC肿瘤基因治疗系统,探讨该系统对小鼠黑色素瘤细胞B16-F10的体外杀伤效应。方法构建重组质粒pGEX-CD,以电穿孔法转化婴儿双歧杆菌,筛选阳性克隆菌,然后加入5-FC厌氧培养,24h后取其上清,作用于小鼠黑色素瘤B16-F10细胞,采用MTT法检测细胞存活率,并观察细胞形态学改变。结果成功构建出婴儿双歧杆菌介导的CD/5-FC肿瘤基因治疗系统。与对照组和pGEX组相比,CD组的肿瘤细胞发生了明显的形态学改变,细胞存活率明显降低。结论婴儿双歧杆菌介导的CD/5-FC系统对小鼠黑色素瘤B16-F10细胞具有明显的体外杀伤效应。 ObjectiveTo construct CD/5-FC tumor gene therapy system delivered by bifidobacterium infantis, and to investigate the killing effect on melanoma B16-F10 cell of mice.MethodsRecombined plasmid pGEX-CD was constructed and transferred into bifidobacterium infants by electroporation. Positive recombined bacteria was selected and identified, and then was incubated with 5-FC in anaerobic condition. The supernatant of bacteria was collected and added to the melanoma B16-F10 cells. The cell growth status was evaluated by MTT assay, and the morphologic changes of cells were observed. ResultsThe CD/5-FC tumor gene therapy system delivered by bifidobacterium infantis has been constructed successfully. The survival rate of cells was significantly lower in CD group than those in control group and in pGEX group,and tumor cells of CD group were remarkably damaged morphologically. ConclusionThe CD/5-FC system delivered by bifidobacterium infantis has the significant killing effect on melanoma B16-F10 cell of mice in vitro.
出处 《医学研究杂志》 2010年第4期49-51,127,共4页 Journal of Medical Research
基金 山东省济宁市科技局重点计划项目
关键词 婴儿双歧杆菌 胞嘧啶脱氨酶(CD) 肿瘤基因治疗 靶向性 Bifidobacterium infantis Cytosine deaminase (CD) Tumor gene therapy Targeting
  • 相关文献

参考文献6

二级参考文献29

  • 1陈纲,李世拥,于波,安平,蔡慧芸.草酸铂、5-氟尿嘧啶联合多药耐药基因反义RNA对耐药直肠癌细胞杀伤作用的研究[J].中华外科杂志,2006,44(11):770-773. 被引量:8
  • 2[2]Yazawa K, Fujimori M, Amano J, et al. Bifidobacterium longum as a delivery system for cancer gene therapy: selective localization and growth in hypoxic tumors. Cancer Gene Ther,2000,7(2):269-274.
  • 3[3]Fujimori M, Amano J, Taniguchi S. The genus Bifidobacterium for cancer gene therapy. Curr Opin Drug Discov Devel,2002,5(2):200-203.
  • 4[4]Nuyts S, Van Mellaert L, Theys J, et al. Clostridium spores for tumor-specific drug delivery. Anticancer Drugs,2002,13(2):115-125.
  • 5Majumdar AS, Zolotorev A, Samuel S, et al. Efficacy of herpes simplex vires thymidine kinase in combination with cytocine gene therapy in an experimental metastatic breast cancer model [ J ]. Cancer Gene Ther,2000, 7(7) : 1086-1099.
  • 6Drozdzik M, Qian C, Xie X, et al. Combined gene therapy with suicide gene and interleukin-12 is more efficient than therapy with one gene alone in a mmine model of hepatocellular carcinoma [ J ]. J Hepatol,2000, 32(2) :279-286.
  • 7Nuyts S, Van Mellaert L, Theys J, et al. Clostridium spores for tumor-specific drug delivery[J]. Anticancer Drug, 2002, 13(2):115-125.
  • 8Yazawa K, Fujimori M, Amano J, et al. Bifidobacterium longum as a delivery system for cancer gene therapy: selective localization and growth in hypoxic tumors[J]. Cancer Gene Ther, 2000, 7(2) :269-274.
  • 9Yazawa K, Fujimon M, Nakamura T, et al. Bifidobacterium longum as a delivery system for gene therapy of chemically induced rat mammary tumors[J]. Breast Cancer Res Treat, 2001,66(2):165-170.
  • 10Fujimori M, Amano J, Taniguchi S. The genus Bifidobacterium for cancer therapy[J]. Curt Opin Drug Discov Devel, 2002, 5(2) :200-203.

共引文献23

同被引文献14

  • 1楚雍烈,答嵘.肿瘤基因治疗载体在临床应用中的问题和研究进展[J].西安交通大学学报(医学版),2006,27(4):313-318. 被引量:3
  • 2Zhang Y, Dai X M, David F. Kallmes, et al. Synthesis of a technetium-99m-labeled thymidine analog: a potential HSV,-TK substrate for non-invasive reporter gene expression imaging[J]. Tetrahedron Letters, 2004(45): 8673-8676.
  • 3Lee KA, Cho K J, Kim S H, et al. IL-18 E42A mutant is resistant to the inhibitory effects of HPV-16 E6 and E7 oncogenes on theIL-18-mediated immune response[J]. Cancer Letters, 2005, 229 (2): 261-270.
  • 4Yazawa K, Fujimori M, Nakamura T, et al. Bifidobacterium longum as a delivery system for cancer gene therapy of chemically induced rat mammary tumors[J]. Breast Cancer Res Treat, 2001, 66(2): 165-170.
  • 5Nakamura T, Sasaki T, Fujimori M, et al. Cloned cytosine deaminase gene expression of Bifidobacterium longum and applica- tion to enzyme/pro-drug therapy of hypoxic solid tumors[J]. Biosci Bio Technol Biochem, 2002, 66(11): 2362-2366.
  • 6Bolotin A, Wincker P, Mauger S, et al. The complete genome sequence of the lactic acid bacterium Ixtctococcus lactis ssp. lactis IL1403[J]. Genome Research, 2001, 11: 731-753.
  • 7Morello E, Bermudez-humaran L G, Llull D, et al. Lactococcus lactis, an efficient cell factory for recombinant protein production and secretion[J]. Journal of Molecular Microbiology and Biotech- nology, 2008, 14: 48-58.
  • 8Mifune J, Grage K, Rehm B H. Production of functionalized bio- polyester granules by recombinant Lactococcus lactis[J]. Applied and Environmental Microbiology, 2009, 75(14): 4668-4675.
  • 9HoLo H, Nes I F. High-frequency transformation by electropota- tion of Lactococus lactis subsp. Cremoris growth with glycine in osmotically stabilized media[J]. Applied and Environmental Micro- biology, 1989, 55(12): 3119-3123.
  • 10Price D J, Miralem T, Jiang S, et al. Role of vascular endo the lial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells[J]. Cell Growth Differ, 2001, 12(3): 129-135.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部